Advantage : Semaglutide Safety Profile# Ecnoglutide : GI adverse events most common
Lets make them stand out
A recent clinical study performed by the manufacturer showed that Fleet Stimulant Oral Laxative and Fleet Liquid Glycerin Suppositories produced a bowel movement after a single dose in 55.9% to 57.1% of GLP-1 patients, and after two doses in 94.1% to 94.3% of GLP-1 patients [21]
OACPPIh: developed using OD-AB, CMCS-PEI, PDA, and iron-hydrated nanoparticles
Unlike standard sterile water preparations, bacteriostatic water contains benzyl alcohol to help support solution stability during repeated withdrawals when sterile laboratory technique is properly followed
Regarding pancreatitis, other data have argued that, Switching between GLP-1 agonists may increase the risk of adverse effects, especially if dose titration protocols are not followed. Noteworthy: Other studies have found that semaglutide and tirzepatide may actually decrease the risk of recurrent acute pancreatitis. Above all, if you suspect you may be developing pancreatitis, consult with your doctor right away, who will likely advise you to stop taking the medication
